Paper40239010
An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update.
Roy S and 8 others. Epigenetics, 2025. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update. Papers, record 40239010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40239010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Epigenesis, Genetic | Major topic |
| Biological Products | Major topic |
| Humans | |
| DNA Methylation | |
| Quercetin | |
| Isothiocyanates | |
| Catechin | |
| Sulfoxides |
Source PubMed
References152
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30605237 | MicroRNA replacement therapy in cancer. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30605237 | PubMed |
| 2 | 32507446 | A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial. | Complement Ther Med | 2020 | https://conductscience.org/library/papers/32507446 | PubMed |
| 3 | 37446908 | Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. | Molecules | 2023 | https://conductscience.org/library/papers/37446908 | PubMed |
| 4 | 29547900 | DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice. | Carcinogenesis | 2018 | https://conductscience.org/library/papers/29547900 | PubMed |
| 5 | 34289845 | Genistein as a regulator of signaling pathways and microRNAs in different types of cancers. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34289845 | PubMed |
| 6 | 33631231 | Natural products in the reprogramming of cancer epigenetics. | Toxicol Appl Pharmacol | 2021 | https://conductscience.org/library/papers/33631231 | PubMed |
| 7 | 33686176 | Dynamic roles of inflammasomes in inflammatory tumor microenvironment. | NPJ Precis Oncol | 2021 | https://conductscience.org/library/papers/33686176 | PubMed |
| 8 | 35629914 | 3,3'-Diindolylmethane Enhances Fluorouracil Sensitivity via Inhibition of Pyrimidine Metabolism in Colorectal Cancer. | Metabolites | 2022 | https://conductscience.org/library/papers/35629914 | PubMed |
| 9 | 31058532 | Cucurbitacin B inhibits cell proliferation and induces cell apoptosis in colorectal cancer by modulating methylation status of BTG3. | Neoplasma | 2019 | https://conductscience.org/library/papers/31058532 | PubMed |
| 10 | 26703571 | The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA Methylation. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/26703571 | PubMed |
| 11 | 28176652 | Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation. | Curr Cancer Drug Targets | 2018 | https://conductscience.org/library/papers/28176652 | PubMed |
| 12 | 31214247 | Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects. | Front Genet | 2019 | https://conductscience.org/library/papers/31214247 | PubMed |
| 13 | 34001246 | Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy. | Clin Epigenetics | 2021 | https://conductscience.org/library/papers/34001246 | PubMed |
| 14 | 37686423 | Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686423 | PubMed |
| 15 | 28989978 | The therapeutic potential of resveratrol: a review of clinical trials. | NPJ Precis Oncol | 2017 | https://conductscience.org/library/papers/28989978 | PubMed |
| 16 | 32903500 | Natural Products Impacting DNA Methyltransferases and Histone Deacetylases. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32903500 | PubMed |
| 17 | 31633039 | Precision treatment in colorectal cancer: Now and the future. | JGH Open | 2019 | https://conductscience.org/library/papers/31633039 | PubMed |
| 18 | 39725830 | Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies. | Mol Biomed | 2024 | https://conductscience.org/library/papers/39725830 | PubMed |
| 19 | 34235089 | Remodeling the Epigenetic Landscape of Cancer-Application Potential of Flavonoids in the Prevention and Treatment of Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34235089 | PubMed |
| 20 | 39061884 | Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39061884 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891767 | Phytochemical modulation of DNMT1-mediated DNA methylation: computational insights into breast cancer. | J Mol Model | 2026 | https://conductscience.org/library/papers/42891767 | PubMed |
| 42396658 | ABCG2 transporter: Structural and functional associations with gout (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42396658 | PubMed |
| 42356528 | Natural Products as Promising Pharmacological Agents Against Cancer: A Holistic Overview of Their Anti-Cancer Mechanisms of Action of the Last Five Years. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356528 | PubMed |
| 42243927 | Histone modifications across cancers: mechanisms, therapy and clinical translation. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42243927 | PubMed |
| 42144517 | Introduction to Cancer Metabolism. | Cancer Treat Res | 2026 | https://conductscience.org/library/papers/42144517 | PubMed |
| 41966661 | Pyroptosis as a double-edged sword in colorectal cancer: Molecular mechanisms and therapeutic opportunities. | Apoptosis | 2026 | https://conductscience.org/library/papers/41966661 | PubMed |
| 41752208 | Suppressive Potential of Ethanolic Extracts of Parkia speciosa Hassk. Empty Pods Against Colon Cancer Cell Migration and Invasion. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752208 | PubMed |
| 41751166 | Diet-Driven Epigenetic Alterations in Colorectal Cancer: From DNA Methylation and microRNA Expression to Liquid Biopsy Readouts. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751166 | PubMed |
| 41714725 | Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/41714725 | PubMed |
| 41439968 | Plant-Derived Antioxidants as Modulators of Redox Signaling and Epigenetic Reprogramming in Cancer. | Cells | 2025 | https://conductscience.org/library/papers/41439968 | PubMed |
| 41249064 | Anticancer potential of dietary fiber for colorectal carcinoma: a narrative review. | Ann Med | 2025 | https://conductscience.org/library/papers/41249064 | PubMed |
| 41155893 | Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41155893 | PubMed |
| 41154590 | Anticancer Activity of Jania rubens in HCT-116 Cells via EMT Suppression, TET Downregulation, and ROS-Mediated Cytotoxicity. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154590 | PubMed |
| 41020873 | Crosstalk Between Metabolic Reprogramming and Epigenetic Modifications in Colorectal Cancer: Mechanisms and Clinical Applications. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41020873 | PubMed |
| 40909922 | Role of curcumin in altering gut microbiota for anti-obesity and anti-hyperlipidemic effects. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40909922 | PubMed |
| 40807355 | Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications. | Molecules | 2025 | https://conductscience.org/library/papers/40807355 | PubMed |
| 40733011 | Acceptability of a Colorectal Cancer-Preventive Diet Promoting Red Meat Reduction and Increased Fiber and Micronutrient Intake: A Cross-Sectional Study in Romanian Adults. | Nutrients | 2025 | https://conductscience.org/library/papers/40733011 | PubMed |
| 40663150 | Epi-nutrients for cancer prevention: Molecular mechanisms and emerging insights. | Cell Biol Toxicol | 2025 | https://conductscience.org/library/papers/40663150 | PubMed |
| 40649998 | Occurrence, Biosynthesis, and Health Benefits of Anthocyanins in Rice and Barley. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649998 | PubMed |
| 40467942 | Advancing the potential of nanoparticles for cancer detection and precision therapeutics. | Med Oncol | 2025 | https://conductscience.org/library/papers/40467942 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40239010
GET https://conductscience.org/api/papers/v1/40239010/references?page=2